Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS)

INR 70.01

(-1.3%)

Market Cap (In INR)

1.45 Billion

Revenue (In INR)

482.09 Million

Net Income (In INR)

29.14 Million

Avg. Volume

190.65 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
48.5-95.6
PE
-
EPS
-
Beta Value
0.383
ISIN
INE947I01017
CUSIP
Y53352103
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Dr. Kuttapalayam Songappan Ramalingam M.D.
Employee Count
-
Website
https://www.lotuseye.org
Ipo Date
2008-07-11
Details
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular lenses, as well as operates an eye bank. In addition, it offers ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.